CAS 1610516-67-0

ML318

CAS: 1610516-67-0

Formula: C₁₄H₈F₄N₂

Purity: 98%

Color and Shape: Solid

Molecular weight: 280.2203

Ref: IN-DA01V74A

ML318

CAS: 1610516-67-0

ML318

Purity: ≥98%

Molecular weight: 280.22g/mol

Ref: 54-BUP05146

ML318

CAS: 1610516-67-0

ML318, a biaryl nitrile, inhibits PvdQ acylase (IC50=20nM) and P. aeruginosa growth (IC50=19µM), blocking pyoverdine production under low iron.

Formula: C₁₄H₈F₄N₂

Purity: 98.93%

Color and Shape: Solid

Molecular weight: 280.22

Ref: TM-T8533

2-(4-Fluorophenyl)-2-(6-(trifluoromethyl)pyridin-2-yl)acetonitrile

CAS: 1610516-67-0

Purity: 98%

Molecular weight: 280.2260132

Ref: 10-F867894

ML318

CAS: 1610516-67-0

ML318 is an analog inhibitor that has shown promising results in the treatment of cancer. It has been found to induce apoptosis in human cancer cells, which makes it a potential candidate for anticancer therapy. ML318 acts as a kinase inhibitor, which means it prevents the activity of enzymes that are involved in cell growth and division. This drug has been tested on various types of tumors, including those found in breast, lung, and prostate cancers. Studies have also shown that ML318 can act as an oxytocin receptor antagonist, which could potentially have therapeutic applications for conditions such as preterm labor or postpartum hemorrhage. Despite its potential benefits, ML318 should be used with caution due to its caffeine-like effects and interactions with other medications.

Formula: C₁₄H₈F₄N₂

Purity: Min. 95%

Molecular weight: 280.22 g/mol

Ref: 3D-KPC51667